Xilio Therapeutics, Inc. ($XLO)
Filing Information
| Accession Number | 0001193125-26-002518 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
107,047
Total Value
$1,174.48
P&L
+inf% (+$694,161.09)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, FINANCE AND ACCOUNTING | Common Stock | โ | Jan 1, 2026 | Exercise/Conversion | 5,000 | โ | โ | 8,197 | Direct | โ | View Details | |
SVP, FINANCE AND ACCOUNTING | Common Stock | โ | Jan 2, 2026 | Sale | 1,826 | $0.64 | $1,174.48 | 6,371 | Direct | โ | View Details | |
SVP, FINANCE AND ACCOUNTING | Stock Option (right to buy) | Derivative | Dec 31, 2025 | Grant/Award | 95,221 | $0.00 | $0.00 | 95,221 | Direct | โ | View Details | |
SVP, FINANCE AND ACCOUNTING | Restricted Stock Units | Derivative | Jan 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 10,000 | Direct | โ | View Details |